A blood pressure test for Dementia

1 August 2019

Neuroscience Innovator, Cognetivity Neurosciences, Looks At Early Diagnosis From New Angle

“The attention accorded to dementia, MCI and degenerative brain conditions has been slow to reach the levels given to the more visibly-quantifiable conditions, such as cardiovascular disease and oncology. But earlier detection of cognitive impairment is a priority, despite therapies not yet being available to halt or reverse the conditions. Playing its part to push back the boundaries is Cognetivity Neurosciences, a London-based company with an innovative tool that uses AI to test subjects for the early signs of dementia.”

Subscribe for updates